RAMM Pharma Corp. Stock

Equities

RAMM

CA75150G1046

Biotechnology & Medical Research

Delayed Canadian Securities Exchange 01:11:51 2024-04-23 pm EDT 5-day change 1st Jan Change
0.06 CAD -7.69% Intraday chart for RAMM Pharma Corp. -7.69% +9.09%
Sales 2022 3.9M 2.84M Sales 2023 5.07M 3.69M Capitalization 5.97M 4.35M
Net income 2022 -21M -15.31M Net income 2023 -7M -5.1M EV / Sales 2022 3.95 x
Net cash position 2022 9.09M 6.63M Net cash position 2023 4.71M 3.44M EV / Sales 2023 0.25 x
P/E ratio 2022
-1.17 x
P/E ratio 2023
-0.78 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 73.72%
More Fundamentals * Assessed data
Dynamic Chart
1 day-7.69%
1 week-7.69%
3 months+20.00%
6 months+20.00%
Current year+9.09%
More quotes
1 month
0.00
Extreme 0
0.07
Current year
0.00
Extreme 0
0.07
1 year
0.00
Extreme 0
0.11
3 years
0.00
Extreme 0
1.04
5 years
0.00
Extreme 0
1.19
10 years
0.00
Extreme 0
1.19
More quotes
Managers TitleAgeSince
Chief Executive Officer - 19-09-30
Director of Finance/CFO - 22-12-08
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 64 19-09-30
Director/Board Member 80 19-09-30
Chief Executive Officer - 19-09-30
More insiders
Date Price Change Volume

Delayed Quote Canadian Securities Exchange, April 23, 2024 at 01:11 pm EDT

More quotes
RAMM Pharma Corp. is a Canada-based company that is engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other hemp-based products with a diversified international production and sales platform. The Company operates a pharmaceutical and medical product business in Uruguay that has developed several medically registered and approved plant-derived cannabinoid pharmaceutical products that have been authorized for sale and/or use in several Latin American countries. The Company has a pipeline of products, including registered hemp-based nutrition and specialized veterinary products, in various stages of approval and development, which are produced at its formulation facility in Montevideo, Uruguay. The Company's brands include NettaPet and NettaVet. Its subsidiaries include Canapar Corp., HemPoland S.p. Z.o.o., Medic Plast SA, Yurelan SA, Glediser SA and RAMM Pharma Holdings Corp.
More about the company